Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

SHA:603669 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	160.78	155.51	254.09	343.42	575.76	986.94
Trading Asset Securities	4.31	13.32	31.22	390.59	389.51	579.13
Cash & Short-Term Investments	165.09	168.83	285.31	734.01	965.28	1,566
Cash Growth	-34.29%	-40.83%	-61.13%	-23.96%	-38.36%	-10.36%
Accounts Receivable	294.73	256.22	243.2	65.6	92.21	124.89
Other Receivables	8.34	2.4	4.69	2.18	3.53	7.71
Receivables	303.07	258.61	247.89	67.78	95.74	132.61
Inventory	75.82	84.03	27.88	56.77	49.14	51.67
Other Current Assets	13.05	13.9	25.53	22.97	21.89	37.95
Total Current Assets	557.03	525.38	586.61	881.53	1,132	1,788
Property, Plant & Equipment	394.16	405.17	469.67	505.35	496.32	484.53
Long-Term Investments	63.96	64.46	75.67	100.87	77.8	66.67
Goodwill	-	-	-	-	-	2.03
Other Intangible Assets	90.39	93.61	100.9	108.44	115.79	124.1
Long-Term Deferred Tax Assets	-	-	-	2.2	0.21	6.83
Long-Term Deferred Charges	10.05	11.42	14.23	17.15	20.1	23.92
Other Long-Term Assets	8.45	6.73	8.25	9.02	13.22	18
Total Assets	1,124	1,107	1,255	1,625	1,855	2,514

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	114.98	108.57	89.13	85.5	49.26	48.53
Accrued Expenses	2.29	13.68	22.06	11.95	14.6	25.25
Short-Term Debt	15.01	15.01	-	117.41	205.24	460.29
Current Portion of Long-Term Debt	287.18	272.6	0.42	0.38	-	85.06
Current Portion of Leases	-	1.94	1.77	2.64	1.14	3.19
Current Income Taxes Payable	20.02	0.11	0.03	0.31	0.02	1.28
Current Unearned Revenue	9.31	11.77	6.88	10.48	8.84	6.61
Other Current Liabilities	9.29	54.9	99.03	14.44	23.33	18.64
Total Current Liabilities	458.06	478.58	219.31	243.11	302.42	648.85
Long-Term Debt	17	-	257.99	439.34	412.52	385.91
Long-Term Leases	2.13	2.13	4.07	5.84	1.07	14.77
Long-Term Unearned Revenue	4.35	4.47	2.41	2.8	4.09	5.81
Long-Term Deferred Tax Liabilities	1.09	1.32	1.78	2.42	0.74	0.19
Total Liabilities	482.64	486.5	485.57	693.52	720.84	1,056

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	712.33	721.25	721.24	721.24	721.24	721.23
Additional Paid-In Capital	253.33	304.4	262.65	255.64	255.63	255.54
Retained Earnings	-334.45	-355.56	-162.32	-31.56	119.94	387.95
Treasury Stock	-50.02	-110.02	-110.02	-108.37	-56.26	-
Comprehensive Income & Other	60.21	60.21	58.21	94.09	94.09	94.11
Shareholders' Equity	641.4	620.28	769.76	931.04	1,135	1,459
Total Liabilities & Equity	1,124	1,107	1,255	1,625	1,855	2,514

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	321.32	291.68	264.26	565.61	619.97	949.22
Net Cash (Debt)	-156.23	-122.85	21.05	168.4	345.3	616.84
Net Cash Growth	-	-	-87.50%	-51.23%	-44.02%	-28.25%
Net Cash Per Share	-0.23	-0.17	0.03	0.23	0.48	0.86
Filing Date Shares Outstanding	686.56	703.54	703.54	703.83	721.24	721.23
Total Common Shares Outstanding	686.56	703.54	703.54	703.83	721.24	721.23
Working Capital	98.96	46.8	367.3	638.42	829.62	1,139
Book Value Per Share	0.93	0.88	1.09	1.32	1.57	2.02
Tangible Book Value	551.01	526.67	668.86	822.61	1,019	1,333
Tangible Book Value Per Share	0.80	0.75	0.95	1.17	1.41	1.85
Buildings	-	366.87	374.09	378.47	369.78	316.92
Machinery	-	142.62	162.03	187.09	191.33	197.49
Construction In Progress	-	190.83	228.22	220.06	190.18	187.96

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error